-
公开(公告)号:US07169777B2
公开(公告)日:2007-01-30
申请号:US10466250
申请日:2002-01-23
申请人: Ryan Thomas Backer , Karin Briner , Ivan Collado Caño , Oscar De Frutos Garcia , Christopher William Doecke , Matthew Joseph Fisher , Cristina Garcia-Paredes , Steven Lee Kuklish , Vincent Mancuso , Michael John Martinelli , Ana Isabel Mateo Herranz , Jeffrey Thomas Mullaney , Paul Leslie Ornstein , Zhipei Wu , Chaoyu Xie
发明人: Ryan Thomas Backer , Karin Briner , Ivan Collado Caño , Oscar De Frutos Garcia , Christopher William Doecke , Matthew Joseph Fisher , Cristina Garcia-Paredes , Steven Lee Kuklish , Vincent Mancuso , Michael John Martinelli , Ana Isabel Mateo Herranz , Jeffrey Thomas Mullaney , Paul Leslie Ornstein , Zhipei Wu , Chaoyu Xie
IPC分类号: A61K31/496 , A61K31/5377 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/14 , A61K31/551
CPC分类号: C07D209/48 , A61K38/00 , C07D209/44 , C07D217/12 , C07D217/16 , C07D217/26 , C07K5/06191
摘要: The present invention relates to melanocortin receptor agonist of the formula I useful in the treatment of obesity, diabetes, and male and/or female sexual dysfunction
摘要翻译: 本发明涉及式I的黑皮质素受体激动剂,其用于治疗肥胖症,糖尿病以及男性和/或女性性功能障碍
-
2.
公开(公告)号:US07157463B2
公开(公告)日:2007-01-02
申请号:US10466249
申请日:2002-01-23
申请人: Ryan Thomas Backer , Karin Briner , Christopher William Doecke , Matthew Joseph Fisher , Steven Lee Kuklish , Vincent Mancuso , Michael John Martinelli , Jeffrey Thomas Mullaney , Chaoyu Xie
发明人: Ryan Thomas Backer , Karin Briner , Christopher William Doecke , Matthew Joseph Fisher , Steven Lee Kuklish , Vincent Mancuso , Michael John Martinelli , Jeffrey Thomas Mullaney , Chaoyu Xie
IPC分类号: A61K31/496 , C07D401/12 , C07D403/12 , C07D403/14
CPC分类号: C07D401/12 , C07D209/44 , C07D217/26 , C07D401/14
摘要: The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
摘要翻译: 本发明涉及式I的黑皮质素受体激动剂,其可用于治疗肥胖症,糖尿病和男性和/或女性性功能障碍
-
公开(公告)号:US07291619B2
公开(公告)日:2007-11-06
申请号:US10466121
申请日:2002-01-23
申请人: Christopher Kelly Biggers , Karin Briner , Christopher William Doecke , Matthew Joseph Fisher , Larry Wayne Hertel , Vincent Mancuso , Michael John Martinelli , John Philip Mayer , Paul Leslie Ornstein , Timothy Ivo Richardson , Jikesh Arvind Shah , Qing Shi , Zhipei Wu , Chaoyu Xie
发明人: Christopher Kelly Biggers , Karin Briner , Christopher William Doecke , Matthew Joseph Fisher , Larry Wayne Hertel , Vincent Mancuso , Michael John Martinelli , John Philip Mayer , Paul Leslie Ornstein , Timothy Ivo Richardson , Jikesh Arvind Shah , Qing Shi , Zhipei Wu , Chaoyu Xie
IPC分类号: A61K31/496 , C07D217/26 , C07D209/44
CPC分类号: A61K45/06 , C07D209/44 , C07D217/14 , C07D217/26 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D417/12
摘要: The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
摘要翻译: 本发明涉及式(I)的黑皮质素受体激动剂,其可用于治疗肥胖症,糖尿病和男性和/或女性性功能障碍
-
4.Piperazine- and piperidine-derivatives as melanocortin receptor agonists 失效
标题翻译: 哌嗪和哌啶衍生物作为黑皮质素受体激动剂公开(公告)号:US07186715B2
公开(公告)日:2007-03-06
申请号:US10466248
申请日:2002-01-23
申请人: Karin Briner , Christopher William Doecke , Vincent Mancuso , Michael John Martinelli , Timothy Ivo Richardson , Roger Ryan Rothhaar , Qing Shi , Chaoyu Xie
发明人: Karin Briner , Christopher William Doecke , Vincent Mancuso , Michael John Martinelli , Timothy Ivo Richardson , Roger Ryan Rothhaar , Qing Shi , Chaoyu Xie
IPC分类号: A61K31/496 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
CPC分类号: A61K45/06 , C07D209/44 , C07D217/14 , C07D217/26 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D417/12
摘要: The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
摘要翻译: 本发明涉及式I的黑皮质素受体激动剂,其可用于治疗肥胖症,糖尿病和男性和/或女性性功能障碍
-
公开(公告)号:US07045545B1
公开(公告)日:2006-05-16
申请号:US09890311
申请日:2000-01-19
申请人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Matthew Joseph Fisher , William Harlan Gritton , Daniel Timothy Kohlman , Sidney Xi Liang , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Yao-Chang Xu , Yanping Xu
发明人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Matthew Joseph Fisher , William Harlan Gritton , Daniel Timothy Kohlman , Sidney Xi Liang , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Yao-Chang Xu , Yanping Xu
IPC分类号: A61K31/36
CPC分类号: C07D307/79 , C07D405/06
摘要: The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.
摘要翻译: 本发明提供式(I)的5-羟色胺氨基烷基苯并呋喃:其中R,R 1,R 2,R 3,R 4, R 4,R 4,R 5,R 5和R 12如上所述 在规范中。
-
公开(公告)号:US06881733B1
公开(公告)日:2005-04-19
申请号:US10031414
申请日:2000-07-21
申请人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Brian Eugene Cunningham , Matthew Joseph Fisher , William Harlan Gritton , Cynthia Darshini Jesudason , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Matthew Robert Reinhard , Roger Ryan Rothhaar , Freddie Craig Stevens , Leonard Larry Winneroski , Yanping Xu , Yao-Chang Xu
发明人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Brian Eugene Cunningham , Matthew Joseph Fisher , William Harlan Gritton , Cynthia Darshini Jesudason , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Matthew Robert Reinhard , Roger Ryan Rothhaar , Freddie Craig Stevens , Leonard Larry Winneroski , Yanping Xu , Yao-Chang Xu
IPC分类号: A61K31/4025 , A61K31/4525 , A61K31/55 , A61P25/24 , C07D405/04 , C07D413/04
CPC分类号: C07D405/04
摘要: The present invention provides serotonergic benzofurans of Formula (I): where A, R, R1, R2, R3, and R4 are as described in the specification.
摘要翻译: 本发明提供式(I)的5-羟色胺能的苯并呋喃:其中A,R,R 1,R 2,R 3和R 3, SUP> 4 SUP>如说明书中所述。
-
7.Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists 失效
标题翻译: 苯并呋喃基哌嗪和苯并呋喃基哌嗪嗪:5-羟色胺激动剂公开(公告)号:US06967201B1
公开(公告)日:2005-11-22
申请号:US10031312
申请日:2000-07-21
申请人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Brian Eugene Cunningham , Matthew Joseph Fisher , William Harlan Gritton , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Matthew Robert Reinhard , Dennis Charles Thompson , Leonard Larry Winneroski , Yanping Xu
发明人: Karin Briner , Joseph Paul Burkhart , Timothy Paul Burkholder , Brian Eugene Cunningham , Matthew Joseph Fisher , William Harlan Gritton , Shawn Christopher Miller , Jeffrey Thomas Mullaney , Matthew Robert Reinhard , Dennis Charles Thompson , Leonard Larry Winneroski , Yanping Xu
IPC分类号: A61K31/496 , A61K31/551 , A61P3/04 , A61P25/24 , A61P43/00 , C07D307/79 , C07D405/04 , C07D405/10 , C07D405/12
CPC分类号: C07D307/79 , C07D405/04 , C07D405/12
摘要: The present invention provides serotonergic benzofurylpiperazines of Formula I: where: A is a piperazine of formula: and R, R1, R2, R3, R4, R5, R5′, R6, R6′, R7, R7′, R8, and R8′ are as described in the specification.
摘要翻译: 本发明提供式I的5-羟色胺苯并呋喃基哌嗪:其中:A是下式的哌嗪和R 1,R 1,R 2,R 3, R 4,R 5,R 5,R 6,R 6,R 6, R SUP,R 7,R 7,R 8和R 8'如上所述 规格。
-
8.6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist 失效
标题翻译: 6-取代的2,3,4,5四氢-1H-苯并[d]吖庚因,为5-HT 2C受体激动剂公开(公告)号:US08580780B2
公开(公告)日:2013-11-12
申请号:US13192707
申请日:2011-07-28
申请人: John Gordon Allen , Karin Briner , Christopher Stanley Galka , Maria Angeles Martinez-Grau , Matthew Robert Reinhard , Michael John Rodriguez , Roger Ryan Rothhaar , Michael Wade Tidwell , Frantz Victor , Deyi Zhang , Steven Armen Boyd , Arundhati S. Deo , Wai-Man Lee , Christopher Stephen Siedem , Ajay Singh
发明人: John Gordon Allen , Karin Briner , Christopher Stanley Galka , Maria Angeles Martinez-Grau , Matthew Robert Reinhard , Michael John Rodriguez , Roger Ryan Rothhaar , Michael Wade Tidwell , Frantz Victor , Deyi Zhang , Steven Armen Boyd , Arundhati S. Deo , Wai-Man Lee , Christopher Stephen Siedem , Ajay Singh
IPC分类号: A61P3/04 , A61P25/22 , A61P25/24 , A61P25/30 , A61K31/55 , C07D223/16 , C07D401/12 , C07D417/12 , C07D413/12 , C07D403/12 , C07D409/12 , C07D405/12 , C07D413/14 , C07D417/06 , C07D403/06
CPC分类号: C07D223/16 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12
摘要: The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where: R6 is —S—R14; and other substituents are as defined in the specification.
摘要翻译: 本发明提供式I的6-取代2,3,4,5-四氢-1H-苯并[d]吖庚因作为选择性5-HT 2C受体激动剂,用于治疗5-HT 2C相关病症,包括肥胖,强迫症/强迫症 ,抑郁症和焦虑症:其中:R6为-S-R14; 和其它取代基如说明书中所定义。
-
9.6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists 有权
标题翻译: 6-N-连接的杂环取代的2,3,4,5-四氢-1H-苯并[d]吖庚因,为5-HT 2C受体激动剂公开(公告)号:US07981882B2
公开(公告)日:2011-07-19
申请号:US11995212
申请日:2006-09-01
申请人: Karin Briner , Anne Marie Camp , Alan Cornell , Michael Philip Mazanetz , Roger Ryan Rothhaar , Frantz Victor , Andrew Caerwyn Williams , Deyi Zhang
发明人: Karin Briner , Anne Marie Camp , Alan Cornell , Michael Philip Mazanetz , Roger Ryan Rothhaar , Frantz Victor , Andrew Caerwyn Williams , Deyi Zhang
IPC分类号: A61P25/24 , A61K31/55 , C07D403/04 , C07D405/14 , C07D409/14 , C07D223/16 , C07D401/14
CPC分类号: C07D403/04 , C07D223/16 , C07D401/14 , C07D405/14 , C07D409/14
摘要: The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: Formula (I) where: R6 is selected from the group consisting of (a, b, c, d, e) and other substituents are as defined in the specification.
摘要翻译: 本发明提供式I的6-取代2,3,4,5-四氢-1H-苯并[d]吖庚因作为选择性5-HT 2C受体激动剂,用于治疗5-HT 2C相关病症,包括肥胖,强迫症/强迫症 ,抑郁症和焦虑症:式(I)其中:R6选自(a,b,c,d,e)和其它取代基如说明书中所定义。
-
10.6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists 失效
标题翻译: 6-取代-2,3,4,5-四氢-1H-苯并[d]吖庚因,为5-HT 2C受体激动剂公开(公告)号:US08420631B2
公开(公告)日:2013-04-16
申请号:US11995344
申请日:2006-09-01
申请人: John Gordon Allen , Karin Briner , Anne Marie Camp , Manuel Javier Cases-Thomas , Richard Charles Hoying , Maria Angeles Martinez-Grau , Michael Philip Mazanetz , Natalia Pokrovskaia , Richard Edmund Rathmell , Roger Ryan Rothhaar , Selma Sapmaz , Andrew Caerwyn Williams
发明人: John Gordon Allen , Karin Briner , Anne Marie Camp , Manuel Javier Cases-Thomas , Richard Charles Hoying , Maria Angeles Martinez-Grau , Michael Philip Mazanetz , Natalia Pokrovskaia , Richard Edmund Rathmell , Roger Ryan Rothhaar , Selma Sapmaz , Andrew Caerwyn Williams
IPC分类号: A61P3/04 , A61P25/00 , A61P25/22 , A61P25/24 , A61K31/55 , C07D223/16 , C07D401/06 , C07D403/04 , C07D409/04 , C07D417/06
CPC分类号: C07D223/16 , C07D401/06 , C07D403/04 , C07D409/04 , C07D417/06
摘要: The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where R6 is —C≡C—R10, —CH═CR11R11′, or —(C0-C8)alkyl-Ar2 optionally substituted on the alkyl moiety with 1 to 6 fluoro substituents and other substituents are as defined in the specification.
摘要翻译: 本发明提供式(I)的6-取代-2,3,4,5-四氢-1H-苯并[d]吖庚因作为选择性5-HT 2C受体激动剂,用于治疗5-HT2C相关疾病,包括肥胖,强迫症 /强迫症,抑郁症和焦虑症:其中R6是-C≡C-R10,-CH = CR11R11'或 - 任选在具有1至6个氟取代基的烷基部分上取代的 - (C 0 -C 8)烷基-Ar 2和其它取代基 如说明书中所定义。
-
-
-
-
-
-
-
-
-